Non-small-cell lung carcinoma
A Case of Synchronous Presentation of Primary Non-Small Cell Lung Carcinoma and Pheochromocytoma
... primary lung cancer and adrenal ...lobe non-small cell lung carcinoma measuring ...primary lung cancer should be ...
6
Seropositive Myasthenia Gravis Associated with Small-Cell Lung Carcinoma
... Background zzLambert-Eaton myasthenic syndrome is well known to be a classical paraneo- plastic syndrome of small cell lung carcinoma (SCLC). Three cases of seronegative myasthenia gravis (MG) ...
4
Expression of MUC1 and MUC4 and Its Prognostic Significance in Non-Small Cell Lung Carcinoma
... 243 lung cancer patients were obtained from curative excision at the Keimyung University Dongsan ...for lung cancer. 15 Cases with histopathologic diagnosis of squa- mous cell carcinoma, ...
7
Risk Factors for Fatal Hemoptysis after Concurrent Chemoradiation Therapy in Patients with Non-Small Cell Lung Carcinoma
... squamous cell carcinoma; ADC, adenocarcinoma; NSCLC, non-small cell lung carcinoma; PR, partial response; SD, stable disease; PD, progressive disease; GP, ...
6
Partial spontaneous remission of small cell lung carcinoma with neurologic symptom
... Small cell lung carcinoma (SCLC) is a cancer that shows aggressive behavior, early spread to distant sites, and frequent association with distinct paraneoplastic ...left lung, ...
4
A Minimal Immunohistochemical Panel for Subtyping Poorly Differentiated Non-Small Cell Lung Carcinoma: A Tissue Microarray Study Simulating Small Biopsy Conditions
... differentiated non-small cell lung carcinoma, IHC: immunohistochemistry, TMA: tissue microarray, CI: confidence interval, TTF-1: thyroid transcription factor-1, ADC: adenocarcinoma, ...
12
Cell Differentiation Might Predict the Recurrence in Surgically Resected Non-Small Cell Lung Carcinoma
... 수술 후 폐암의 항암화학치료는 IA기 폐암에서는 권고 되지 않고 있고 13,14 IB, II기 폐암에서는 권고되고 있고 생 존율을 높이고 재발률을 줄인다는 여러 연구가 있지만 Adjuvant Lung Cancer Project Italy (ALPI), International Adjuvant Lung Cancer (IALT) 연구에서는 II기암에서 항 암화학치료가 ...
6
Efficacy and Safety of Pemetrexed in Advanced Non-Small Cell Lung Carcinoma
... 통계적으로 유의하게 길었다(p=0.016). 병리 조직(non- squamous cell ca./squmous cell ca.), 병기, 흡연 여부, 성별 그리고 항암 치료 차수에 따른 생존 중앙값 및 관해 지속 중앙값은 통계적 유의성이 없었다. 다변량 분석 시 관해 지속 중앙값에 영향을 미칠 것으로 예상 되는 병리 ...
6
Promoter Methylation of and in Non-Small Cell Lung Carcinoma: Quantitative Evaluation Using Pyrosequencing
... Figure 2. Survival analysis in CDKN2A (A), RARβ (B), RASSF1A (C) promoter with hypermethylation and un- methylation in non-small cell lung cancer. can be used for analyzing DNA methylation at ...
11
Overexpression of Periostin Protein in Non-Small Cell Lung Carcinoma is Not Related with Clinical Prognostic Significance
... the carcinoma cells, with very little expression in the tumor cells themselves 22 ...the small diameter of each specimen and relatively unfamiliar peritumoral im- unostaining pattern, relatively concurred ...
8
A Case of Cancer Associated Retinopathy with Small Cell Lung Carcinoma
... Cancer associated retinopathy (CAR) syndrome is a very rare ocular manifestation of paraneoplastic syndrome, and is characterized clinically by progressive visual im[r] ...
5
Anticancer and Immunomodulatory Effects of Formosa Plum Extracts on Non-small Cell Lung Carcinoma, NCI-H520, Xenograft Mice
... Objectives : The object of this study was to observe anticancer and immunomodulatory effects of Formosa plum aqueous extracts (PLe) on non-small cell lung carcino[r] ...
7
Anticancer and Related Immunomodulatory Effects of Insamyangyoung-tang on Non-small Cell Lung Carcinoma, NCI-H520, Xenograft Mice
... Fig. Changes on the serum IFN-γ levels after Insamyangyoung-tang extracts administrations.. Changes on the splenic NK cell activities after Insamyangyoung-tang extracts administ[r] ...
20
Anticancer and Related Immunomodulatory Effects of Kwibi-tang on Non-small Cell Lung Carcinoma, NCI-H520, Xenograft Mice
... 누드 마우스는 가슴샘이 없어, T 임파구 매개성 세포 면역이 현저히 억제되어, 사람의 종양세포를 포함한 다양한 종양 이식 동물모델로 이용되고 있 으나 47 , 연령이 증가함에 따라, 가슴샘 밖에서 T 임 파구의 성숙이 서서히 일어나며, 말초 혈액에서도 완전히 T 임파구가 소실되는 것이 아니라, 연령에 따라, 천천히 증가되는 것으로 알려져 있고, 특히 세포독성 T ...
18
A Case of Patient with Non-Small Cell Lung Carcinoma Treated with Samchilchoongcho-Jung in Conjunction with Crizotinib
... words: Carcinoma, Non-Small-Cell Lung, crizotinib, anaplastic lymphoma kinase, Samchilchoongcho-Jung 서 론 폐암은 암으로 인한 사망의 주요 원인으로, 2017 년 미국의 통계에 따르면 폐암은 남녀에서 각각 암으로 인한 사망의 27%와 25%를 차지 ...
10
Molecular Pathogenesis of Non-Small Cell Lung Carcinomas
... of Non-Small Cell Lung Carcinomas Non-small cell lung carcinoma (NSCLC) from histological and biological perspectives is a complex ...squamous cell ...
9
Immunotherapy for Non-Small Cell Lung Cancer
... Initially, squamous cell carcinoma had been considered to show better response to nivolumab. However, that result was not clear at the follow up. Only 14% of patients had the 3 or 4 stages of drug toxicity ...
5
CT findings of mediastinal lymph node metastasis in bronchogenic carcinoma of the lung: A comparative study of small cell carcinoma vs non-small cell carcinoma
... We analyzed retrospectively CT scans of 3 1 patients with pathologically proven bron chogen ic carcino ma of the lung who had med iastinal lymph node metas tasis w[r] ...
A Case of Residual Non-Small Cell Lung Cancer Cells Coexisting With Newly Developed Small Cell Lung Cancer Cells in Ascitic Fluid after Chemotherapy for Non-Small Cell Lung Cancer
... primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and ...primary lung cancers via p53 pathway induced by heavy ...
3
Lobectomy versus Sublobar Resection in Non-Lepidic Small-Sized Non-Small Cell Lung Cancer
... Therefore, the effect of tumor subtype (such as aci- nar, papillary, solid, or micropapillary) on survival af- ter sublobar resection was insufficiently examined in our study. Micropapillary and solid-type tumors are ...
9